Clicky

Bristol-Myers Squibb Company(BRM) News

Date Title
Feb 17 Why Bristol-Myers Squibb (BMY) Is Among the Best Drug Stocks to Buy Now
Feb 16 New Five-Year Sotyktu (deucravacitinib) Data Show Consistent Safety and Durable Response Rates in Moderate-to-Severe Plaque Psoriasis
Feb 14 BioArctic AB (BRCTF) Q4 2024 Earnings Call Highlights: Strategic Partnerships and Profitability ...
Feb 13 Bristol Myers Squibb Provides Update on Phase 3 RELATIVITY-098 Trial
Feb 12 Bristol-Myers Squibb Company (BMY) – Jim Cramer: “No, No, You Don’t Hold”
Feb 12 Shareholders in Bristol-Myers Squibb (NYSE:BMY) have lost 7.2%, as stock drops 5.4% this past week
Feb 11 BMY Down 7% Post Q4 Earnings: Should You Buy, Sell or Hold the Stock?
Feb 11 Jim Cramer on Bristol-Myers (BMY): Cobenfy’s Success vs. Patent Headwinds
Feb 11 BMS’ Phase II trial of CAR T cell therapy meets primary endpoint
Feb 11 The Magnificent 7 Are So Last Year. Cash Cows Are the New Kings.
Feb 10 Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It
Feb 10 Royalty Pharma Earnings: What To Look For From RPRX
Feb 10 Bristol Myers Squibb Announces Positive Topline Results for Breyanzi® (lisocabtagene maraleucel) in Adult Patients with Relapsed or Refractory Marginal Zone Lymphoma
Feb 1 No One Knows How to Price AI Tools
Feb 1 Why Bristol-Myers Squibb Company (BMY) Is Among the Best Long Term Low Risk Stocks to Buy Now
Jan 31 Top Dividend Stocks Yielding As High As 5%: Fidelity
Jan 31 Stocks to watch next week: Amazon, Palantir, Disney, Novo Nordisk and AstraZeneca
Jan 31 Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Jan 31 Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo® (nivolumab) plus Yervoy® (ipilimumab) as a First-Line Treatment Option for Adult Patients with Unresectable or Advanced Hepatocellular Carcinoma
Jan 31 Bristol Myers Squibb Receives Positive CHMP Opinion for CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma